A Medicare pricing policy that takes into account a drug’s added therapeutic benefit could be used to reduce costs for expensive Part B drugs with low added benefit, according to study results by Drs. Michael J. DiStefano and Kelly Anderson.
April 1, 2024CU Anschutz
Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
Aurora, CO 80045